SOS Limited Unsponsored ADR (NYSE:SOS – Get Free Report) shares traded up 10.5% on Monday . The company traded as high as $1.1699 and last traded at $1.1050. 155,378 shares traded hands during trading, an increase of 576% from the average daily volume of 22,997 shares. The stock had previously closed at $1.00.
Analyst Ratings Changes
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of SOS in a research note on Thursday, June 11th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.
Check Out Our Latest Research Report on SOS
SOS Stock Performance
SOS (NYSE:SOS – Get Free Report) last released its quarterly earnings data on Friday, May 15th. The company reported ($669.48) earnings per share for the quarter. The company had revenue of $32.35 million during the quarter.
Institutional Investors Weigh In On SOS
An institutional investor recently bought a new position in SOS stock. Invesco Ltd. acquired a new stake in shares of SOS Limited Unsponsored ADR (NYSE:SOS – Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 315,968 shares of the company’s stock, valued at approximately $439,000. Invesco Ltd. owned approximately 4.65% of SOS as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 1.92% of the company’s stock.
SOS Company Profile
SOS Limited is a China-based specialty chemical company that develops, manufactures and markets a broad portfolio of water treatment, glycol and surfactant products. Founded in 1997 and headquartered in Shanghai, the company focuses on delivering high-performance solutions for industrial, municipal and household applications. Its core mission is to address water conservation and pollution control challenges while supporting downstream industries with essential chemical inputs.
The company’s primary offerings include a range of water treatment chemicals such as coagulants, flocculants and scale inhibitors designed for use in power plants, petrochemical facilities, and municipal waterworks.
Featured Articles
- Five stocks we like better than SOS
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for SOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SOS and related companies with MarketBeat.com's FREE daily email newsletter.
